Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis
Background: Calcific atherosclerosis is a major challenge to intraluminal drug delivery in peripheral artery disease (PAD). Objectives: We evaluated the effects of orbital atherectomy on intraluminal paclitaxel delivery to human peripheral arteries with substantial calcified plaque. Methods: Diagnos...
Main Authors: | Zani, Brett, Stanley, James, Muraj, Benny, Knutson, Jennifer, Kohler, Robert, Markham, Peter, Nikanorov, Alexander, Tzafriri, A Rami, Garcia Polite, Fernando, Edelman, Elazer R |
---|---|
Other Authors: | Massachusetts Institute of Technology. Institute for Medical Engineering & Science |
Format: | Article |
Published: |
Elsevier
2017
|
Online Access: | http://hdl.handle.net/1721.1/112760 https://orcid.org/0000-0002-7832-7156 |
Similar Items
-
Impact of lesion preparation-induced calcified plaque defects in vascular intervention for atherosclerotic disease: in silico assessment
by: Sogbadji, Jonas, et al.
Published: (2025) -
Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis
by: Bleijerveld, Onno B., et al.
Published: (2014) -
HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages
by: Sanchez-Gaytan, Brenda L., et al.
Published: (2016) -
In vivo Raman spectral pathology of human atherosclerosis and vulnerable plaque
by: Motz, Jason T., et al.
Published: (2014) -
Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings
by: Tzafriri, Abraham R., et al.
Published: (2020)